New NASs reviewed by medicine prices review board Canada 2011-2017 by improvement

The Patented Medicine Prices Review Board reviewed one NAS classified as a substantial improvement in 2017. This statistic depicts the new active substances (NASs) reviewed by the Patented Medicine Prices Review Board in Canada from 2011 to 2017, by therapeutic improvement.

Number of new active substances (NASs) reviewed by PMPRB Canada from 2011 to 2017, by therapeutic improvement*

BreakthroughSubstantial ImprovementModerate ImprovementSlight/no improvementOther**
2011-19133
201214585
2013427252
2014-32128
2015-151516
20161-51418
2017216198
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Canada

Survey time period

2011 to 2017

Supplementary notes

* The year of reporting reflects the year in which the Notice of Compliance was issued rather than the year that the PMPRB conducted its price review.
Medicines reviewed by the PMPRB prior to the implementation of the 2010 Guidelines have been merged as follows: category 2 medicines are included in the Breakthrough category; category 1 medicines are included in the Slight/No Improvement category; and category 3 medicines are included in the Moderate Improvement category.
** New active substances not reported to the PMPRB as of the 2016 Annual Report.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.